This project is designed to study mechanisms of ion transport and the factors which control membrane permeability in mitochondria. A primary objective is to characterize the K+/H+ antiporter with respect to its physiological role, the mechanism by which it is regulated by Mg++ ions and the mechanism by which it carries out electroneutral exchange of K+ for H+ across the inner membrane of mitochondria. Pharmacological inhibition of the K+/H+ antiporter and other ion transport pathways by quinine and other antimalarials will be studied in detail to determine the molecular site of action of these drugs. Development and application of quantitative thermodynamic transport equations will be required in order to characterize the ion-specific pathways which may operate simultaneously during experimental protocols. These studies will be carried out in rat liver mitochondria using ion electrodes, radioisotopes, atomic absorption spectroscopy and light scattering to measure transport. We have recently identified an 82 kDa, dicyclohexylcarbodiimide-binding protein which we believe to be responsible for K+/H+ antiport in liver mitochondria. This finding makes feasible a program designed to reconstitute a functionally active, purified K+/H+ antiporter into lipid vesicles. This program will utilize chromatography, electrophoresis and other protein fractionation procedures. K+ is the major cation of both cytosol and mitochondrial matrix. Net K+ transport into mitochondria necessarily results in matrix swelling. I have postulated that the K+/H+ antiporter is regulated through reversible inhibition by Mg++ ions and that this interaction provides a dynamic, finely tuned mechanism for matrix volume homeostasis in vivo. It is possible that the delicate balance of this K+ cycle is disturbed in pathophysiological processes. This project is designed to improve our understanding of ion transport mechanisms generally and to determine how these processes are integrated into the general energy economy of the cell.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM031086-05
Application #
3279006
Study Section
Physical Biochemistry Study Section (PB)
Project Start
1982-07-01
Project End
1990-07-31
Budget Start
1986-08-01
Budget End
1987-07-31
Support Year
5
Fiscal Year
1986
Total Cost
Indirect Cost
Name
University of Toledo
Department
Type
Schools of Medicine
DUNS #
807418939
City
Toledo
State
OH
Country
United States
Zip Code
43614
Grover, G J; Garlid, K D (2000) ATP-Sensitive potassium channels: a review of their cardioprotective pharmacology. J Mol Cell Cardiol 32:677-95
Garlid, K D (2000) The state of water in biological systems. Int Rev Cytol 192:281-302
Garlid, K D; Jabyyrek, M; Jezek, P et al. (2000) How do uncoupling proteins uncouple? Biochim Biophys Acta 1459:383-9
Jabyyrek, M; Varecha, M; Gimeno, R E et al. (1999) Transport function and regulation of mitochondrial uncoupling proteins 2 and 3. J Biol Chem 274:26003-7
Jezek, P; Zackova, M; Rehakova, Z et al. (1999) Existence of uncoupling protein-2 antigen in isolated mitochondria from various tissues. FEBS Lett 455:79-82
Garlid, K D; Jabyyrek, M; Jezek, P (1998) The mechanism of proton transport mediated by mitochondrial uncoupling proteins. FEBS Lett 438:10-4
Jezek, P; Modriansky, M; Garlid, K D (1997) Inactive fatty acids are unable to flip-flop across the lipid bilayer. FEBS Lett 408:161-5
Jezek, P; Modriansky, M; Garlid, K D (1997) A structure-activity study of fatty acid interaction with mitochondrial uncoupling protein. FEBS Lett 408:166-70
Yarov-Yarovoy, V; Paucek, P; Jabyyrek, M et al. (1997) The nucleotide regulatory sites on the mitochondrial KATP channel face the cytosol. Biochim Biophys Acta 1321:128-36
Garlid, K D; Paucek, P; Yarov-Yarovoy, V et al. (1997) Cardioprotective effect of diazoxide and its interaction with mitochondrial ATP-sensitive K+ channels. Possible mechanism of cardioprotection. Circ Res 81:1072-82

Showing the most recent 10 out of 45 publications